124 related articles for article (PubMed ID: 31222941)
1. Scaffolds for Sustained Release of Ambroxol Hydrochloride, a Pharmacological Chaperone That Increases the Activity of Misfolded β-Glucocerebrosidase.
Enshaei H; Molina BG; Del Valle LJ; Estrany F; Arnan C; Puiggalí J; Saperas N; Alemán C
Macromol Biosci; 2019 Aug; 19(8):e1900130. PubMed ID: 31222941
[TBL] [Abstract][Full Text] [Related]
2. A comparative computational approach toward pharmacological chaperones (NN-DNJ and ambroxol) on N370S and L444P mutations causing Gaucher's disease.
Thirumal Kumar D; Iyer S; Christy JP; Siva R; Tayubi IA; George Priya Doss C; Zayed H
Adv Protein Chem Struct Biol; 2019; 114():315-339. PubMed ID: 30635084
[TBL] [Abstract][Full Text] [Related]
3. Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase.
Bendikov-Bar I; Maor G; Filocamo M; Horowitz M
Blood Cells Mol Dis; 2013 Feb; 50(2):141-5. PubMed ID: 23158495
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease.
Maegawa GH; Tropak MB; Buttner JD; Rigat BA; Fuller M; Pandit D; Tang L; Kornhaber GJ; Hamuro Y; Clarke JT; Mahuran DJ
J Biol Chem; 2009 Aug; 284(35):23502-16. PubMed ID: 19578116
[TBL] [Abstract][Full Text] [Related]
5. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
Kibria G; Islam KM; Jalil RU
Pak J Pharm Sci; 2009 Jan; 22(1):36-43. PubMed ID: 19168418
[TBL] [Abstract][Full Text] [Related]
6. An oral controlled release system for ambroxol hydrochloride containing a wax and a water insoluble polymer.
Chi N; Guo JH; Zhang Y; Zhang W; Tang X
Pharm Dev Technol; 2010; 15(1):97-104. PubMed ID: 19671037
[TBL] [Abstract][Full Text] [Related]
7. Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate.
Migdalska-Richards A; Ko WKD; Li Q; Bezard E; Schapira AHV
Synapse; 2017 Jul; 71(7):. PubMed ID: 28295625
[TBL] [Abstract][Full Text] [Related]
8. Whey protein concentrate doped electrospun poly(epsilon-caprolactone) fibers for antibiotic release improvement.
Ahmed SM; Ahmed H; Tian C; Tu Q; Guo Y; Wang J
Colloids Surf B Biointerfaces; 2016 Jul; 143():371-381. PubMed ID: 27022878
[TBL] [Abstract][Full Text] [Related]
9. Star poly(ε-caprolactone)-based electrospun fibers as biocompatible scaffold for doxorubicin with prolonged drug release activity.
Bala Balakrishnan P; Gardella L; Forouharshad M; Pellegrino T; Monticelli O
Colloids Surf B Biointerfaces; 2018 Jan; 161():488-496. PubMed ID: 29128835
[TBL] [Abstract][Full Text] [Related]
10. In situ controlled release of rhBMP-2 in gelatin-coated 3D porous poly(ε-caprolactone) scaffolds for homogeneous bone tissue formation.
Zhang Q; Tan K; Zhang Y; Ye Z; Tan WS; Lang M
Biomacromolecules; 2014 Jan; 15(1):84-94. PubMed ID: 24266740
[TBL] [Abstract][Full Text] [Related]
11. Ambroxol effects in glucocerebrosidase and α-synuclein transgenic mice.
Migdalska-Richards A; Daly L; Bezard E; Schapira AH
Ann Neurol; 2016 Nov; 80(5):766-775. PubMed ID: 27859541
[TBL] [Abstract][Full Text] [Related]
12. Anti-Neoplastic Cytotoxicity of SN-38-Loaded PCL/Gelatin Electrospun Composite Nanofiber Scaffolds against Human Glioblastoma Cells In Vitro.
Zhu X; Ni S; Xia T; Yao Q; Li H; Wang B; Wang J; Li X; Su W
J Pharm Sci; 2015 Dec; 104(12):4345-4354. PubMed ID: 26505475
[TBL] [Abstract][Full Text] [Related]
13. Core-shell poly(lactide-co-ε-caprolactone)-gelatin fiber scaffolds as pH-sensitive drug delivery systems.
Sang Q; Li H; Williams G; Wu H; Zhu LM
J Biomater Appl; 2018 Mar; 32(8):1105-1118. PubMed ID: 29295656
[TBL] [Abstract][Full Text] [Related]
14. Poly(ε-caprolactone)/triclosan loaded polylactic acid nanoparticles composite: A long-term antibacterial bionanocomposite with sustained release.
Kaffashi B; Davoodi S; Oliaei E
Int J Pharm; 2016 Jul; 508(1-2):10-21. PubMed ID: 27155590
[TBL] [Abstract][Full Text] [Related]
15. Combined beta-glucosylceramide and ambroxol hydrochloride in patients with Gaucher related Parkinson disease: From clinical observations to drug development.
Ishay Y; Zimran A; Szer J; Dinur T; Ilan Y; Arkadir D
Blood Cells Mol Dis; 2018 Feb; 68():117-120. PubMed ID: 27866808
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of doxycycline-loaded electrospun PCL/PEO membranes for a potential drug delivery system.
Eskitoros-Togay ŞM; Bulbul YE; Tort S; Demirtaş Korkmaz F; Acartürk F; Dilsiz N
Int J Pharm; 2019 Jun; 565():83-94. PubMed ID: 31063838
[TBL] [Abstract][Full Text] [Related]
17. Gradiently degraded electrospun polyester scaffolds with cytostatic for urothelial carcinoma therapy.
Wang J; Wang G; Shan H; Wang X; Wang C; Zhuang X; Ding J; Chen X
Biomater Sci; 2019 Feb; 7(3):963-974. PubMed ID: 30569055
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of the ambroxol action in Gaucher disease and GBA1 mutation-associated Parkinson disease.
Cyske Z; Gaffke L; Rintz E; Wiśniewska K; Węgrzyn G; Pierzynowska K
Neurochem Int; 2024 May; 178():105774. PubMed ID: 38797393
[TBL] [Abstract][Full Text] [Related]
19. Functional screening of pharmacological chaperones via restoration of enzyme activity upon denaturation.
Shanmuganathan M; Britz-McKibbin P
Biochemistry; 2012 Oct; 51(39):7651-3. PubMed ID: 22970758
[TBL] [Abstract][Full Text] [Related]
20. rhEGF microsphere formulation and in vitro skin evaluation.
Al Haushey L; Bolzinger MA; Fessi H; Briançon S
J Microencapsul; 2010; 27(1):14-24. PubMed ID: 19212891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
